AVP and autosomal recessive polycystic kidney disease: OPC31260 also improved the PCK AVP−/− ARPKD rat, reducing both cAMP and kidney-specific ERK phosphorylation, and overall improving water reabsorption, reducing kidney cysts and weight compared to vehicle-treated controls [122].